AKT1 and cancer: Another component of TME, mesenchymal stem cells (MSCs), is found to derive exosomes that enhance GC malignant properties and induce the epithelial‐mesenchymal transition (EMT) and cancer stemness in GC cells by activating the Akt signalling pathway.44, 45, 46